Tumor polo-like kinase 4 protein expression reflects lymphovascular invasion, higher Federation of Gynecology and Obstetrics stage, and shortened survival in endometrial cancer patients who undergo surgical resection

Qinyan Zhao,Minli Wang,Mingcong Chen

DOI: https://doi.org/10.1186/s12905-024-02911-9

2024-02-07

Abstract:Abstract Background Polo-like kinase 4 (PLK4) serves as a marker for tumor features and poor outcomes in cancers. This study aimed to explore the associations of tumor PLK4 protein expression with tumor characteristics and survival in endometrial cancer (EC) patients who underwent surgical resection. Methods This study included 142 EC patients who underwent surgical resection. Tumor tissue samples were obtained for tumor PLK4 protein expression detection via immunohistochemistry (IHC). Results Among EC patients, 26.1% had a PLK4 IHC score of 0, 24.6% had a score of 1–3, 27.5% had a score of 4–6, and 21.8% had a score of 7–12. Tumor PLK4 protein expression positively associated with lymphovascular invasion ( P = 0.008) and Federation of Gynecology and Obstetrics (FIGO) stage ( P = 0.005). Disease-free survival (DFS) was not different between patients with tumor PLK4 IHC scores > 0 and ≤ 0 ( P = 0.154) but was reduced in patients with scores > 3 vs. ≤ 3 ( P = 0.009) and > 6 vs. ≤ 6 ( P 0 and ≤ 0 ( P = 0.322) but was shorter in patients with scores > 3 vs. ≤ 3 ( P = 0.011) and > 6 vs. ≤ 6 ( P = 0.006). After adjustment, a tumor PLK4 IHC score > 6 (vs. ≤ 6) (hazard ratio (HR): 3.156, P = 0.008) or > 3 (vs. ≤ 3) (HR: 3.918, P = 0.026) was independently associated with shortened DFS and OS. Conclusion A tumor PLK4 IHC score > 6 or > 3 associates with shortened DFS and OS in EC patients who undergo surgical resection.

public, environmental & occupational health,obstetrics & gynecology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the association between the expression of Polo - like kinase 4 (PLK4) protein in tumors and tumor characteristics and survival after surgical resection in patients with endometrial cancer (EC). Specifically, the study aims to:

1. **Evaluate the expression of PLK4 protein in endometrial cancer**: Analyze the expression level of PLK4 protein by immunohistochemistry (IHC) in tumor tissue samples from 142 endometrial cancer patients who underwent surgical resection.
2. **Explore the relationship between PLK4 protein expression and tumor characteristics**: Investigate the relationship between PLK4 protein expression and tumor characteristics such as lymphatic vessel invasion and International Federation of Gynecology and Obstetrics (FIGO) staging.
3. **Evaluate the impact of PLK4 protein expression on survival**: Analyze the relationship between PLK4 protein expression and disease - free survival (DFS) and overall survival (OS) to determine its potential value as a prognostic marker.

### Main findings:
- **Relationship between PLK4 protein expression and tumor characteristics**:
- High PLK4 protein expression is significantly associated with lymphatic vessel invasion (P = 0.008).
- High PLK4 protein expression is significantly associated with a higher FIGO stage (P = 0.005).

- **Relationship between PLK4 protein expression and survival**:
- Compared with patients with a PLK4 IHC score of ≤3, patients with a score of >3 have a significantly shorter DFS (P = 0.009).
- Compared with patients with a PLK4 IHC score of ≤6, patients with a score of >6 have a significantly shorter DFS (P < 0.001).
- Compared with patients with a PLK4 IHC score of ≤3, patients with a score of >3 have a significantly shorter OS (P = 0.011).
- Compared with patients with a PLK4 IHC score of ≤6, patients with a score of >6 have a significantly shorter OS (P = 0.006).

### Results of multivariate Cox regression analysis:
- **Independent prognostic factors**:
- A tumor PLK4 IHC score of >6 (vs. ≤6) is independently associated with a shorter DFS (hazard ratio [HR]: 3.156, P = 0.008) and OS (HR: 3.918, P = 0.026).
- Other independent prognostic factors include: high - grade endometrioid cancer (G3), serous endometrial cancer, clear - cell endometrial cancer, hypertension, and a higher FIGO stage.

### Conclusion:
The expression level of tumor PLK4 protein (especially with an IHC score of >6 or >3) is associated with a shorter DFS and OS in patients with endometrial cancer and can serve as an independent prognostic marker. These findings are helpful for predicting disease progression and survival outcomes and provide a reference for clinical treatment.